The Mumps Vaccine (MumpsVax) Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The market size for the mumps vaccine (mumpsvax) has been increasing over recent years. The market worth grew from $2,057.93 million in 2024 to an expected $2,210.59 million in 2025, with a compound annual growth rate (CAGR) of 7.4%.
The mumps vaccine (MumpsVax) global market is expected to reach $2,902.21 million by 2029, growing at a compound annual growth rate (CAGR) of 7.0%.
Download Your Free Sample of the 2025 Mumps Vaccine (MumpsVax) Market Report and Uncover Key Trends Now!The key drivers in the mumps vaccine mumpsvax market are:
• A rise in prevalence of infectious diseases leads to increased demand for preventative measures such as vaccinations, boosting the mumps vaccine market.
• Increased healthcare expenditure globally enhances access to and immunization rates for the mumps vaccine, encouraging market growth.
• Increasing clinical trials that study viral infections and pediatric immunization strategies contribute to the growth of the mumps vaccine market.
• Changes in human demographics, behavior, and urbanization increasing the chances for disease transmission indirectly stimulate the need for mumps vaccinations, supporting market growth.
The mumps vaccine (mumpsvax) market covered in this report is segmented –
1) By Product Type: Monovalent, Combinational, Divalent, Trivalent, Other Product Types
2) By Age Group: Pediatric, Adult
3) By Distribution Channels: Hospital pharmacies, Drug Stores, Retail Pharmacies
4) By End-User: Pediatric Clinic, Hospitals, Non-Governmental Organization (NGOs), Other End-Users
The key trends in the mumps vaccine mumpsvax market are:
• Rising demand for long-acting ESAs is a prominent market trend.
• Technological advancements are continuously influencing the market.
• Development of healthcare infrastructure is shaping future adoption.
• There is an increasing focus on patient-centric drug delivery systems.
Major players in the mumps vaccine mumpsvax market are:
• Merck & Co. Inc.
• GlaxoSmithKline plc
North America is the leading region in the mumps vaccine (MumpsVax) market as of 2024.